Murine IFN gamma ELISpot Set

Diaclone
Product Code: 862.031.001
Product Group: ELISpot Kits
Supplier: Diaclone
CodeSizePrice
862.031.0011 x 96 Discovery (plate not included)£197.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Mouse
Regulatory Status: RUO
Application: ELISpot

Further Information

Additional 2:
Spots read visually or with reader
Antigen Synonyms:
IFN-g IFN-gamma
Cross reaction:
No cross reactivity with other murine cytokines
Description:
Diaclone ELISpot Sets include capture and detection antibodies Streptavidin - Alkaline Phosphatase conjugated BSA BCIP/NTB blocking reagent.
Detection Target:
IFN gamma
Incubation:
3h after cell stimulation
Reactivity:
Murine
Research Area:
Cytokines / Growth Factors
Specificity:
Recognizes natural murine IFN-g

References

  1. Abadie V. et al.PLoS One2009; 4(12): e8159. Original encounter with antigen determines antigen-presenting cell imprinting of the quality of the immune response in mice. https://www.ncbi.nlm.nih.gov/pubmed/19997562
  2. Adotevi O.et al. Blood2010; 115(15): 3025-3032. Targeting human telomerase reverse transcriptase with recombinant lentivector is highly effective to stimulate antitumor CD8 T-cell immunity in vivo. https://www.ncbi.nlm.nih.gov/pubmed/20130242
  3. Adriouch S. et al. Front Microbiol.2011; 2: 199. Improved Immunological Tolerance Following Combination Therapy with CTLA-4/Ig and AAV-Mediated PD-L1/2 Muscle Gene Transfer.. https://www.ncbi.nlm.nih.gov/pubmed/22046170
  4. Ascough S. et al. Front Microbiol.2016;6:1506 . CD4+ T Cells Targeting Dominant and Cryptic Epitopes from Bacillus anthracis Lethal Factor. https://www.ncbi.nlm.nih.gov/pubmed/26779161
  5. Ascough S. et al. PLoS Pathog.2014; 10(5): e1004085. Anthrax lethal factor as an immune target in humans and transgenic mice and the impact of HLA polymorphism on CD4+ T cell immunity.. https://www.ncbi.nlm.nih.gov/pubmed/24788397
  6. Attaf M. et al. Sci Rep.2016; 6: 35006.. alphabeta T cell receptor germline CDR regions moderate contact with MHC ligands and regulate peptide cross-reactivity.. https://www.ncbi.nlm.nih.gov/pubmed/27775030
  7. Bergwerf I. et al.BMC Biotechnol.2009; 9: 1.. Reporter gene-expressing bone marrow-derived stromal cells are immune-tolerated following implantation in the central nervous system of syngeneic immunocompetent mice. https://www.ncbi.nlm.nih.gov/pubmed/19128466
  8. Bialkowski L. et al. Sci Rep.2016;6:22509 . Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumours. https://www.ncbi.nlm.nih.gov/pubmed/26931556
  9. Bonduelle O. et al. J. Immunol. 2012; 188: 952 - 956. Protective Effect of CX3CR1+ Dendritic Cells in a Vaccinia Virus Pulmonary Infection Model. https://www.ncbi.nlm.nih.gov/pubmed/22219332
  10. Calvet C. Y. et al. Mol Ther Methods Clin Dev.2014?; 1: 14045. Optimization of a gene electrotransfer procedure for efficient intradermal immunization with an hTERT-based DNA vaccine in mice. https://www.ncbi.nlm.nih.gov/pubmed/26015983
  11. Chen A. et al. J. Virol. 2005; 79(9): 5568 - 5576. H-2 Kd-Restricted Hepatitis B Virus-Derived Epitope Whose Specific CD8+ T Lymphocytes Can Produce Gamma Interferon without Cytotoxicity. https://www.ncbi.nlm.nih.gov/pubmed/15827171
  12. Cox F. et al. PLoS One2015; 10(12): e0145243. Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells.. https://www.ncbi.nlm.nih.gov/pubmed/26696245
  13. DossetM. et al.Oncoimmunology. 2018 Mar 15;7(6):e1433981.. PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer.. https://www.ncbi.nlm.nih.gov/pubmed/29872568
  14. Dunachie S.J. et al.Sci Rep. 2017 Sep 22;7(1):12143.. Infection with Burkholderia pseudomallei - immune correlates of survival in acute melioidosis.. https://www.ncbi.nlm.nih.gov/pubmed/28939855
  15. Gaidot A. et al. Blood2011?; 117(10): 2975-2983. Immune reconstitution is preserved in hematopoietic stem cell transplantation coadministered with regulatory T cells for GVHD prevention. https://www.ncbi.nlm.nih.gov/pubmed/21193693